4//SEC Filing
Emerson Andrew 4
Accession 0000874716-25-000129
CIK 0000874716other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 6:00 PM ET
Size
8.3 KB
Accession
0000874716-25-000129
Insider Transaction Report
Form 4
Emerson Andrew
EVP, CFO and Treasurer
Transactions
- Tax Payment
Common Stock
2025-08-07$650.06/sh−402$261,324→ 3,870.778 total - Exercise/Conversion
Common Stock
2025-08-07$141.60/sh+1,849$261,818→ 4,272.778 total - Exercise/Conversion
Incentive Stock Option (right-to-buy)
2025-08-07−1,849→ 0 totalExercise: $141.60Exp: 2027-02-13→ Common Stock (1,849 underlying)
Footnotes (3)
- [F1]Includes a total of 27.3420 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
- [F2]Grant of option to buy 1,849 shares of Issuer common stock that vested on February 14, 2022.
- [F3]Not applicable.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeother
Related Parties
1- filerCIK 0002058587
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 6:00 PM ET
- Size
- 8.3 KB